(Q41676871)

6 October 2017

1 reference

title

The potential for clinical guidelines to impact appropriate antimicrobial agent use. (English)

1 reference

6 October 2017

Gross PA

1

1 reference

6 October 2017

publication date

1 December 1997

1 reference

Infectious Disease Clinics of North America

6 October 2017

published in

1 reference

6 October 2017

volume

11

1 reference

6 October 2017

issue

4

1 reference

6 October 2017

page(s)

803-812

1 reference

Infectious disease surveillance: a crumbling foundation

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Management of a restricted drugs policy in hospital: the first five years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Formulary control of antimicrobial usage. What price freedom?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Intervention to discontinue parenteral antimicrobial therapy in hospitalized patients with urinary tract infection, skin and soft tissue infection, or no evident infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Computer surveillance of hospital-acquired infections and antibiotic use

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Purpose of quality standards for infectious diseases. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Quality standard for the treatment of bacteremia. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Positive Foley catheter tip cultures--fact or fancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Indicators for assessment of compliance with quality standards for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

The value of surveillance cultures on neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Evaluation of Antibiotic Usage: A Comprehensive Look at Alternative Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Confronting multidrug resistance. A role for each of us

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Clearance from a hospital of gram-negative bacilli that transfer carbenicillin-resistance to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Relation of the inanimate hospital environment to endemic nosocomial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Usage of antibiotics in a general hospital: effect of requiring justification

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Role of the infectious disease specialist in containing costs of antibiotics in the hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Can antibiotic resistance be controlled?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Testing the physician's knowledge of antibiotic use: Self-assessment and learning via videotape

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Restriction policies for therapy with combination antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Infectious complications of indwelling vascular catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

The failure of physician education as a cost containment strategy. Report of a prospective controlled trial at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Managed care and the infectious diseases specialist

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970391-3

7 January 2021

10.1016/S0891-5520(05)70391-3

Identifiers

DOI

1 reference

6 October 2017

1 reference